1. 2357 Prognostic factors in 709 advanced gastric cancer patients exposed to second-line therapy. (September 2015) Authors: Fontanella, C.; Fanotto, V.; Uccello, M.; Vasile, E.; Bozzarelli, S.; Filippi, R.; Santini, D.; Rosati, G.; Tomasello, G.; Silvestris, N.; Pietrantonio, F.; Bergamo, F.; Cinieri, S.; Melisi, D.; Antonuzzo, L.; Fornaro, L.; Cordio, S.; Pasquini, G.; Rimassa, L.; Aprile, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 65P Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large real life worldwide population. (December 2022) Authors: Rimini, M.; Casadei Gardini, A.; Persano, M.; Suda, G.; Tada, T.; Shimose, S.; Kudo, M.; Cheon, J.; Finkelmeier, F.; Rimassa, L.; Presa, J.; Masi, G.; Yoo, C.; Lonardi, S.; Tovoli, F.; Piscaglia, F.; Iavarone, M.A.; Scartozzi, M.; Burgio, V.; Cascinu, S. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 67P Real-world data for atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. (December 2022) Authors: Persano, M.; Rimini, M.; Tada, T.; Suda, G.; Shimose, S.; Kudo, M.; Cheon, J.; Finkelmeier, F.; Rimassa, L.; Presa, J.; Masi, G.; Yoo, C.; Lonardi, S.; Piscaglia, F.; Burgio, V.; Scartozzi, M.; Cascinu, S.; Casadei Gardini, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study. (June 2017) Authors: Comito, Tiziana; Cozzi, L.; Clerici, E.; Franzese, C.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Tronconi, M. C.; De Rose, F.; Franceschini, D.; Ascolese, A. M.; Fogliata, A.; Tomatis, S.; Santoro, A.; Zerbi, A.; Scorsetti, M. Journal: Technology in cancer research & treatment Issue: Volume 16:Number 3(2017:Jun.) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?. Issue 8 (3rd August 2018) Authors: Baretti, M.; Personeni, N.; Destro, A.; Santoro, A.; Rimassa, L. Journal: Cancer biology & therapy Issue: Volume 19:Issue 8(2018) Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EP-1430 Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients. (April 2019) Authors: Comito, T.; Franzese, C.; Clerici, E.; Navarria, P.; D'Agostino, G.R.; Carrara, S.; Rimassa, L.; Tomatis, S.; Zerbi, A.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extra-hepatic tumor recurrence after directly-acting-antiviral (DAA) therapy in HCV patients. (February 2019) Authors: Torres, M.C. Plaz; Lamonaca, L.; Nalda, A. Lleo De; Ceriani, R.; Rimassa, L.; Personeni, N.; Colombo, M.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hepatic and extrahepatic colorectal metastases: discordant pathologic responses to systemic therapy in patients undergoing simultaneous resection of multiple tumor sites. (2021) Authors: Corleone, P.; Viganò, L.; Rimassa, L.; Del Fabbro, D.; Di Tommaso, L.; Torzilli, G. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer. Issue 4 (July 2016) Authors: Di Bartolomeo, Maria; Pietrantonio, Filippo; Rulli, Eliana; Poli, Davide; Berenato, Rosa; Caporale, Marta; Bajetta, Emilio; Floriani, Irene; Bajetta, E.; Di Bartolomeo, M.; Catena, L.; Schiavo, M.; Pinotti, G.; Proserpio, I.; Rosati, G.; Bordonaro, R.; Cordio, S.; Burrafato, G.; Bochicchio, A.M.;... Journal: Tumori Issue: Volume 102:Issue 4(2016) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. L07Baseline characteristics and survival outcomes of advanced gastric cancer patients treated with two or more lines of chemotherapy: results from a large Italian cohort. (26th September 2015) Authors: Ferrari, L.; Fontanella, C.; Uccello, M.; Pasquini, G.; Bozzarelli, S.; Filippi, R.; Imperatori, M.; Ferrara, D.; Tomasello, G.; Brunetti, O.; Pietrantonio, F.; Bellu, L.; Lutrino, E.S.; Melisi, D.; Antonuzzo, L.; Musettini, G.; Cordio, S.; Vivaldi, C.; Rimassa, L.; Aprile, G. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗